This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer for ProfessionalsYour Resource Portal

Ophthalmology Learning Zone
View more
Bayer Ophthalmology Masterclass Programme
Interactive meetings and a range of online resources to refresh your knowledge
PP-EYL-GB-2702, January 2025
Bitesize OCT Knowledge Checkers
Test your knowledge of OCT disease biomarkers in this series of OCT images
PP-EYL-GB-2892, August 2025
Oncology Learning Zone
View more
Request An Interactive Pharmacist’s Guide
NUBEQA® (darolutamide)
PP-NUB-GB-2388, May 2025
NUBEQA® (darolutamide) Drug-Drug Interactions Learning Guide
PP-NUB-GB-2129, March 2025
Module 4: MI Course
Xofigo®▼ (radium-223 dichloride) | NUBEQA® (darolutamide)
RP-NUB-GB-0713, January 2025
Module 3: MI Course
Xofigo®▼ (radium-223 dichloride) | NUBEQA® (darolutamide)
RP-NUB-GB-0712, January 2025
Women's Health Learning Zone
View more
Urogenital Symptoms and Sexual Difficulties
(5 mins) Often underreported and undertreated symptoms that significantly affect a woman's relationships.
PP-PF-WHC-IUS-GB-0085 October 2024
Musculoskeletal Symptoms, Anxiety, Low Mood and Brain Fog
(4 mins) Causes for musculoskeletal (MSK) symptoms, how menopause can worsen existing anxiety and depression.
PP-PF-WHC-IUS-GB-0084 October 2024
Relationship Between Flushes and Sweats, Sleep and Mood
(4 mins) Vasomotor symptoms (VMS), sleep disturbances, and mood changes are distressing menopause symptoms.
PP-PF-WHC-IUS-GB-0083 October 2024
Menopausal Flushes and Sweats
(5 mins) Learn about vasomotor symptoms, the proportion of women experiencing them and lifestyle risk factors.
PP-PF-WHC-IUS-GB-0082 October 2024